Joel Greenblatt Biogen Inc. Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Biogen Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 163,489 shares of BIIB stock, worth $25.4 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
163,489
Previous 99,228
64.76%
Holding current value
$25.4 Million
Previous $13.6 Million
51.22%
% of portfolio
0.13%
Previous 0.12%
Shares
31 transactions
Others Institutions Holding BIIB
# of Institutions
1,056Shares Held
131MCall Options Held
2.84MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.69 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.46 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.26 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.16 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$746 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...